Developing small molecules to target pain-related receptors
Official title: Administrative Core
Funded at Univ of North Carolina Chapel Hill · NIH-10974393 · Data updated 2026-11-12
This study is all about finding new tiny medicines that can help manage pain better, and it's designed for people who are looking for more effective ways to relieve their discomfort.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | September 19, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $396,573 |
| NIH project number | 1U19NS138975-01 |
| Project ID | NIH-10974393 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research are individuals experiencing chronic pain conditions.
✕Less likely to help
Patients with acute pain or those not experiencing pain-related conditions may not receive benefit from this research.
What this research studies
This research focuses on creating new small molecules that can interact with specific receptors involved in the perception of pain. The project is led by a team of experienced researchers who will work collaboratively to ensure effective communication and coordination throughout the development process. Patients may benefit from advancements in pain management through the potential discovery of more effective analgesic treatments. The Administrative Core will provide essential support to facilitate this interdisciplinary effort.
Why it matters
Potential benefit: If successful, this research could lead to improved pain management options for patients suffering from chronic pain.
How similar studies have gone: Other research has shown promise in developing targeted analgesic therapies, indicating that this approach has potential for success.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Scherrer, Gregory — Univ of North Carolina Chapel Hill
- Study coordinator: Scherrer, Gregory
Related research
Other NIH-funded projects on the same topics.
-
A center for coordinating data related to heart and blood health.
This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.
-
Healthy work design and worker well-being
A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.
-
Unified and fair multimodal learning for autoimmune diseases
A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.
-
Structural factors linking minimum wage, COVID-19, and community violence
A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
How HPV interacts with our cells' DNA damage system and its effect on cancer
This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.